Editor's perspectives – June 2016

June 2016

esigner drugs, research chemicals, novel psychoactive substances (NPS), and legal highs are all terms used to describe drugs designed to skirt legal controls. Although the trend toward using these drugs picked up steam in the new millennium, the search for new recreational substances— either through repurposing pharmaceutical research or modifying existing drugs of abuse—is not new. The second ...

In the June 2016 issue

ADEA Staff (as of June 2016).

DIVISION OF COMMUNICATIONS AND MEMBERSHIP Mr. Robert Moran, Interim Senior Vice President for Communications and Membership Ms. Kellie Bove, Director of Marketing and Communications Mr. Sean Carter, Senior Membership Manager Mr. Derek Day, Communications and Membership Associate Ms. Laura Iverson, Publications Manager and Writer Ms. Susan Kimner, Director of Publishing Ms. Nancy Lang, Senior Pu...

Aptamers in Bordeaux, 24–25 June 2016

The symposium covered the many different aspects of the selection and the characterization of aptamers as well as their application in analytical, diagnostic and therapeutic areas. Natural and artificial riboswitches were discussed. Recent advances for the design of mutated polymerases and of chemically modified nucleic acid bases that provide aptamers with new properties were presented. The po...

ADMET June 13-14 2016, London, UK

ADME and toxicology testing are one of the most important research activities related to new drug discovery. Ensuring a good ADMET study will accelerate approval and therefore commercialization of your drug product – and hence pharmacokinetics remain at the forefront of drug formulation and development Since the pharmaceutical and biotechnology companies are utilising innovative technologies, A...